Eric Lefkofsky is one of the medical technology world’s biggest up and comers. In the past, his technology startups have become industry changing, including Groupon, which he also founded. His latest venture has become a bit of a unicorn in the technology space. Tempus was founded in 2015 and its over arching goal is to take a new approach to help drive the fight to cure cancer. When technology leaders like Eric Lefkofsky put their expertise and knowledge to use, true innovation comes into the medical community. Lefkofsky has long since been known as a major contributor to cancer research. As having someone near to you go through cancer treatment typically does, Lefkofsky was more motivated than ever to contribute to cancer research. He did this by bringing his technology skills to the field of research.
While Tempus is still technically a startup, in the past 2 years it has received more than $130 million in funding. Among those that funded it is cofounder Eric Lefkofsky and his partner. Most recently, Tempus announced that their series C funding round generated 70 million in funds. This puts the company’s evaluation at an estimated $700 million dollars. Tempus is a name on the lips of many people in the health tech startup field. It’s goal is to build the world’s first ever operating system that will modernize the treatment of cancer and how data is collected and shared by oncologists everywhere.
Tempus wants to make cancer treatment data driven in order to highly personalize it to each patient. Tempus uses a cutting edge technology called genomic sequencing in order to analyze the patient’s individual biochemistry and type of cancer to provide the best method possible to treat that specific cancer or tumor better.
Tempus also is an operational system that collects, processes, analyzes and stores huge amounts of data. Data has typically been stored in physicians’ notes and while there is a lot of data, there is no central, digitized system that physicians can access. By being able to access this data, Tempus helps patients make the most custom plan for their pateint’s health and cancer treatment plan.
When it comes to disrupting industries, Eric Lefkofsky is no stranger. Lefkofsky is founder of Groupon and is a major tech figure in Chicago. He has donated millions of dollars toward cancer research in lifetime. Now, he has created a startup that will take an innovate approach in fighting cancer.
Tempus is a health-tech startup that seeks to modernize treatment for cancer. His company’s innovative approach purposes itself to help healthcare professionals make decisions in real-time. Doctors will be able to analyze a patient’s genetic context in tandem with therapies on the molecular level. Indeed, it is high-tech. Cutting edge analysis methods and genomic sequencing will help medical professionals to better understand a patient’s tumor.
He received his education from the University of Michigan, and the University of Michigan Law School. His foundation focuses on several key areas: Education, human rights, medical research, and arts and culture. Much of his philanthropy takes place in his hometown of Chicago. Arts and culture receive the largest share of donations. Eric Lefkofsky and his wife Liz offer strong support for children’s charter schools, after-school programs for disadvantaged youth, and various scholarship programs. One of the most innovative programs supported by he and his wife may be MoneyThink.
The program provides mentors who help teach financial education in urban schools.
Many philanthropists operate quietly and their contributions often go unnoticed by the public. Perhaps this is the way that it should be. It may indicate a desire to remain out of the spotlight and focus on the things in life that count for others. The Lefkovsky Family Foundation also partnered with the Motorola Mobility Foundation and Google to create 1871 FEMtech. FEMtech encourages women to break into the field of entrepreneurship in the following: http://www.lightbank.com/team/eric-lefkofsky click here.
His life also underscores the importance of education. As such, he is in step with the “life of his times” and is able to leverage his education and drive to help others.
If you have been searching for ways to potentially improve your writing, then you should not worry as there are a vast array of opportunities for you to do so with the number of resources that are available for people to utilize online today. Oncotarget has been recognized as a multidisciplinary traditional journal that provides users with absolute free access. It publishes weekly issues of papers online. Every paper or issues is capable of being printed for special demand. The mission of Oncotarget is to produce results quickly while making them available on a large scale. In order to maximize the impact of research through the utilization of insightful reviews, one will need to conduct thorough instances of research and analysis so that they may allow great discoveries to be shared rapidly.
There are a vast array of reasons why one should do what they need to do to master their writing. Oncotarget offers periodicals to be read which are uploaded onto its website on a regular basis. You will be able to learn about the latest happenings and what solutions there may have been to certain problems that may be shown. It is truly a great website in which people may be able to find written materials that they need to accomplish certain tasks, such a projects, homework, work tasks, and possibly more. Read more on Dovepress.
If you’re wanting to learn more about Oncotarget, it’s recommended for you to go on their website so that you may learn about what all they have to offer. You will see that the site has contact information on it along with a vast array of many other links. It is a beautifully created and engineered website that has been designed with elements of simplicity. The minimalist approach to the website’s designing has enabled it to give visitors an impression that the website has been made with seriousness as its motive in which people should go there to learn, as opposed to wasting time on things that aren’t necessarily useful for what the site’s purpose is, or what one should be on there for.